Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2021 Sep 20;110:106571. doi: 10.1016/j.cct.2021.106571

Table 2.

Scenarios (rate of ePTB) for investigating whether DHA status at enrollment impacts the effect of DHA supplementation.

Dose (g/day)
Scenario DHA 0 (n=350) 0.2 (n=700) 0.45 (n=175) 0.6 (n=180) 0.8 (n=150) 1 (n=550)
1 (optimistic) High 1.56% 1.56% 1.56% 1.56% 1.56% 1.56%
Low 11.01% 8.19% 6.20% 5.43% 4.69% 4.16%
2 (no effect) High 6.27% 4.90% 3.91% 3.52% 3.13% 2.85%
Low 6.27% 4.90% 3.91% 3.52% 3.13% 2.85%